2,393
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Patterns of retinal thickness prior to and following treatment with fluocinolone acetonide 190 µg intravitreal implant for diabetic macular edema

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Yusuf Mushtaq, Maryam M Mushtaq, Zisis Gatzioufas, Matteo Ripa, Lorenzo Motta & Georgios D Panos. (2023) Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies. Drug Design, Development and Therapy 17, pages 961-975.
Read now
Sarah E. Holden, Maged Habib & Craig J. Currie. (2020) Retinal thickness fluctuations in patients receiving fluocinolone acetonide implant for diabetic macular edema. Current Medical Research and Opinion 36:6, pages 959-965.
Read now
Jessica D McCluskey, Paul L Kaufman, Kathy Wynne & Gregory Lewis. (2019) Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME). International Medical Case Reports Journal 12, pages 93-102.
Read now
Sarah E. Holden, Craig J. Currie & David R. Owens. (2017) Health-economic evaluation of fluocinolone acetonide 190 µg implant in people with diabetic macular edema. Current Medical Research and Opinion 33:sup2, pages 45-52.
Read now
Craig J. Currie, Sarah E. Holden, Ellen Berni & David R. Owens. (2017) Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes. Current Medical Research and Opinion 33:sup2, pages 19-31.
Read now
Simon Dixon. (2017) Determining the relative cost effectiveness of the fluocinolone acetonide intravitreal implant. Current Medical Research and Opinion 33:sup2, pages 1-2.
Read now

Articles from other publishers (5)

Maria Vittoria Cicinelli, Alessandro Rabiolo, Luigi Capone, Carlo Di Biase, Rosangela Lattanzio & Francesco Bandello. (2022) Factors associated with the response to fluocinolone acetonide 0.19  mg in diabetic macular oedema evaluated as the area-under-the-curve. Eye 37:2, pages 242-248.
Crossref
Raquel Estebainha, Raquel Goldhardt & Manuel Falcão. (2020) A New Approach for Diabetic Macular Edema Treatment: Review of Clinical Practice Results with 0.19 mg Fluocinolone Acetonide Intravitreal Implant Including Vitrectomized Eyes. Current Ophthalmology Reports 8:1, pages 1-10.
Crossref
Angela Carneiro, Angelina Meireles, João Paulo Castro Sousa & Carla Teixeira. (2020) Clinical impact of the 0.2 µg/day fluocinolone acetonide intravitreal implant: outcomes from the ILUVIEN ® clinical evidence study in Portugal . Therapeutic Advances in Ophthalmology 12, pages 251584142091776.
Crossref
Horace Massa, Anindyt M. NagarAthanasios Vergados, Panagiotis Dadoukis, Sudeshna Patra & Georgios D. Panos. (2018) Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review. Journal of International Medical Research 47:1, pages 31-43.
Crossref
William Fusi-Rubiano, Rebecca R. Blow, Mark Lane, Rupal Morjaria & Alastair K. Denniston. (2018) Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review. Ophthalmology and Therapy 7:2, pages 293-305.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.